| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| LLY - Eli Lilly and Company | BUY | 1,492 @ USD 762.73 | USD 1,137,993 | The ETF bought 1492 new shares of LLY (Eli Lilly and Company). The shares were bought for an average price of 762.73 compared to the previous average buy price of 832.356. This is -8.4% lower than average price of previous purchases of LLY. |
| ABBV - AbbVie Inc | BUY | 5,257 @ USD 185.3 | USD 974,122 | The ETF bought 5257 new shares of ABBV (AbbVie Inc). The shares were bought for an average price of 185.3 compared to the previous average buy price of 192.622. This is -3.8% lower than average price of previous purchases of ABBV. |
| ABT - Abbott Laboratories | BUY | 7,248 @ USD 132.99 | USD 963,912 | The ETF bought 7248 new shares of ABT (Abbott Laboratories). The shares were bought for an average price of 132.99 compared to the previous average buy price of 127.638. This is 4.2% higher than average price of previous purchases of ABT. |
| ISRG - Intuitive Surgical Inc | BUY | 1,784 @ USD 509.36 | USD 908,698 | The ETF bought 1784 new shares of ISRG (Intuitive Surgical Inc). The shares were bought for an average price of 509.36 compared to the previous average buy price of 537.804. This is -5.3% lower than average price of previous purchases of ISRG. |
| JNJ - Johnson & Johnson | BUY | 5,772 @ USD 149.79 | USD 864,588 | The ETF bought 5772 new shares of JNJ (Johnson & Johnson). The shares were bought for an average price of 149.79 compared to the previous average buy price of 157.337. This is -4.8% lower than average price of previous purchases of JNJ. |
| BSX - Boston Scientific Corporation | BUY | 6,661 @ USD 101.3 | USD 674,759 | The ETF bought 6661 new shares of BSX (Boston Scientific Corporation). The shares were bought for an average price of 101.3 compared to the previous average buy price of 99.0356. This is 2.3% higher than average price of previous purchases of BSX. |
| BSX - MULSTRXSSXIMETFP | BUY | 6,661 @ USD 101.3 | USD 674,759 | The ETF bought 6661 new shares of BSX (MULSTRXSSXIMETFP). The shares were bought for an average price of 101.3 compared to the previous average buy price of 99.0356. This is 2.3% higher than average price of previous purchases of BSX. |
| PFE - Pfizer Inc | BUY | 24,104 @ USD 23.97 | USD 577,773 | The ETF bought 24104 new shares of PFE (Pfizer Inc). The shares were bought for an average price of 23.97 compared to the previous average buy price of 25.5985. This is -6.4% lower than average price of previous purchases of PFE. |
| AMGN - Amgen Inc | BUY | 1,689 @ USD 289.33 | USD 488,678 | The ETF bought 1689 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 289.33 compared to the previous average buy price of 301.699. This is -4.1% lower than average price of previous purchases of AMGN. |
| SYK - Stryker Corporation | BUY | 1,173 @ USD 375.56 | USD 440,532 | The ETF bought 1173 new shares of SYK (Stryker Corporation). The shares were bought for an average price of 375.56 compared to the previous average buy price of 379.004. This is -0.9% lower than average price of previous purchases of SYK. |
| BMY - Bloomsbury Publishing Plc | BUY | 8,267 @ USD 46.86 | USD 387,392 | The ETF bought 8267 new shares of BMY (Bloomsbury Publishing Plc). The shares were bought for an average price of 46.86 compared to the previous average buy price of 56.1587. This is -16.6% lower than average price of previous purchases of BMY. |
| VRTX - Vertex Pharmaceuticals Inc | BUY | 815 @ USD 440.87 | USD 359,309 | The ETF bought 815 new shares of VRTX (Vertex Pharmaceuticals Inc). The shares were bought for an average price of 440.87 compared to the previous average buy price of 474.32. This is -7.1% lower than average price of previous purchases of VRTX. |
| CVS - CVS Health Corp | BUY | 5,352 @ USD 66.57 | USD 356,283 | The ETF bought 5352 new shares of CVS (CVS Health Corp). The shares were bought for an average price of 66.57 compared to the previous average buy price of 63.3062. This is 5.2% higher than average price of previous purchases of CVS. |
| MDT - Medtronic PLC | BUY | 3,625 @ USD 86.34 | USD 312,983 | The ETF bought 3625 new shares of MDT (Medtronic PLC). The shares were bought for an average price of 86.34 compared to the previous average buy price of 88.4502. This is -2.4% lower than average price of previous purchases of MDT. |
| GILD - Guild Esports Plc | BUY | 2,315 @ USD 108.5 | USD 251,178 | The ETF bought 2315 new shares of GILD (Guild Esports Plc). The shares were bought for an average price of 108.5 compared to the previous average buy price of 103.568. This is 4.8% higher than average price of previous purchases of GILD. |
| PODD - Insulet Corporation | BUY | 675 @ USD 303.15 | USD 204,626 | The ETF bought 675 new shares of PODD (Insulet Corporation). The shares were bought for an average price of 303.15 compared to the previous average buy price of 272.402. This is 11.3% higher than average price of previous purchases of PODD. |
| LH - Laboratory Corporation of America Holdings | BUY | 719 @ USD 261.88 | USD 188,292 | The ETF bought 719 new shares of LH (Laboratory Corporation of America Holdings). The shares were bought for an average price of 261.88 compared to the previous average buy price of 243.401. This is 7.6% higher than average price of previous purchases of LH. |
| GEHC - GE HealthCare Technologies Inc. | BUY | 2,546 @ USD 71.28 | USD 181,479 | The ETF bought 2546 new shares of GEHC (GE HealthCare Technologies Inc.). The shares were bought for an average price of 71.28 compared to the previous average buy price of 83.2716. This is -14.4% lower than average price of previous purchases of GEHC. |
| HUM - Hummingbird Resources PLC | BUY | 731 @ USD 239.62 | USD 175,162 | The ETF bought 731 new shares of HUM (Hummingbird Resources PLC). The shares were bought for an average price of 239.62 compared to the previous average buy price of 266.685. This is -10.1% lower than average price of previous purchases of HUM. |
| HUM - Humana Inc | BUY | 731 @ USD 239.62 | USD 175,162 | The ETF bought 731 new shares of HUM (Humana Inc). The shares were bought for an average price of 239.62 compared to the previous average buy price of 266.685. This is -10.1% lower than average price of previous purchases of HUM. |
| SOLV - Solventum Corp. | BUY | 2,327 @ USD 73.57 | USD 171,197 | The ETF bought 2327 new shares of SOLV (Solventum Corp.). The shares were bought for an average price of 73.57 compared to the previous average buy price of 73.9854. This is -0.6% lower than average price of previous purchases of SOLV. |
| MCK - McKesson Corporation | BUY | 237 @ USD 720.92 | USD 170,858 | The ETF bought 237 new shares of MCK (McKesson Corporation). The shares were bought for an average price of 720.92 compared to the previous average buy price of 634.538. This is 13.6% higher than average price of previous purchases of MCK. |
| BAX - Baxter International Inc | BUY | 5,419 @ USD 29.99 | USD 162,516 | The ETF bought 5419 new shares of BAX (Baxter International Inc). The shares were bought for an average price of 29.99 compared to the previous average buy price of 32.922. This is -8.9% lower than average price of previous purchases of BAX. |
| WAT - Waters Corporation | BUY | 466 @ USD 342.63 | USD 159,666 | The ETF bought 466 new shares of WAT (Waters Corporation). The shares were bought for an average price of 342.63 compared to the previous average buy price of 365.98. This is -6.4% lower than average price of previous purchases of WAT. |
| WAT - MULETFWATIMETFP | BUY | 466 @ USD 342.63 | USD 159,666 | The ETF bought 466 new shares of WAT (MULETFWATIMETFP). The shares were bought for an average price of 342.63 compared to the previous average buy price of 365.98. This is -6.4% lower than average price of previous purchases of WAT. |
| BIIB - Biogen Inc | BUY | 1,248 @ USD 127.04 | USD 158,546 | The ETF bought 1248 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 127.04 compared to the previous average buy price of 143.398. This is -11.4% lower than average price of previous purchases of BIIB. |
| RMD - ResMed Inc | BUY | 569 @ USD 253.68 | USD 144,344 | The ETF bought 569 new shares of RMD (ResMed Inc). The shares were bought for an average price of 253.68 compared to the previous average buy price of 236.002. This is 7.5% higher than average price of previous purchases of RMD. |
| A - Agilent Technologies Inc | BUY | 1,234 @ USD 115.56 | USD 142,601 | The ETF bought 1234 new shares of A (Agilent Technologies Inc). The shares were bought for an average price of 115.56 compared to the previous average buy price of 127.409. This is -9.3% lower than average price of previous purchases of A. |
| COR - Cencora Inc. | BUY | 482 @ USD 293.66 | USD 141,544 | The ETF bought 482 new shares of COR (Cencora Inc.). The shares were bought for an average price of 293.66 compared to the previous average buy price of 259.48. This is 13.2% higher than average price of previous purchases of COR. |
| DHR - Danaher Corporation | BUY | 211 @ USD 196.39 | USD 41,438 | The ETF bought 211 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 196.39 compared to the previous average buy price of 214.206. This is -8.3% lower than average price of previous purchases of DHR. |
| DHR - Danaher Corporation | BUY | 211 @ USD 196.39 | USD 41,438 | The ETF bought 211 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 196.39 compared to the previous average buy price of 214.206. This is -8.3% lower than average price of previous purchases of DHR. |
| TECH - Bio-Techne Corp | SELL | -174 @ USD 49.89 | USD -8,681 | The ETF sold 174 shares of TECH on 2025-06-20. The shares were previously bought for an average price of USD 63.1863. The Bio-Techne Corp shares were sold for -21.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,314 The average price that the ETF previously sold TECH share for is USD 69.2202 which is higher than the selling price of USD 49.89 on 2025-06-20. |
| MRNA - Moderna Inc | SELL | -368 @ USD 25.9 | USD -9,531 | The ETF sold 368 shares of MRNA on 2025-06-20. The shares were previously bought for an average price of USD 34.2369. The Moderna Inc shares were sold for -24.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,068 The average price that the ETF previously sold MRNA share for is USD 40.6293 which is higher than the selling price of USD 25.9 on 2025-06-20. |
| HSIC - Henry Schein Inc | SELL | -138 @ USD 71.98 | USD -9,933 | The ETF sold 138 shares of HSIC on 2025-06-20. The shares were previously bought for an average price of USD 72.5185. The Henry Schein Inc shares were sold for -0.7% lower than average price of previous purchases. This resulted in an overall loss of USD 74 The average price that the ETF previously sold HSIC share for is USD 71.1138 so the ETF has sold 138 shares on 2025-06-20 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -62 @ USD 171.7 | USD -10,645 | The ETF sold 62 shares of UHS on 2025-06-20. The shares were previously bought for an average price of USD 187.055. The Universal Health Services Inc shares were sold for -8.2% lower than average price of previous purchases. This resulted in an overall loss of USD 952 The average price that the ETF previously sold UHS share for is USD 191.823 which is higher than the selling price of USD 171.7 on 2025-06-20. |
| VTRS - Viatris Inc | SELL | -1,338 @ USD 8.87 | USD -11,868 | The ETF sold 1338 shares of VTRS on 2025-06-20. The shares were previously bought for an average price of USD 10.2428. The Viatris Inc shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,837 The average price that the ETF previously sold VTRS share for is USD 11.9071 which is higher than the selling price of USD 8.87 on 2025-06-20. |
| INCY - Incyte Corporation | SELL | -178 @ USD 68.46 | USD -12,186 | The ETF sold 178 shares of INCY on 2025-06-20. The shares were previously bought for an average price of USD 68.9882. The Incyte Corporation shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 94 The average price that the ETF previously sold INCY share for is USD 72.1692 which is higher than the selling price of USD 68.46 on 2025-06-20. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -224 @ USD 69.47 | USD -15,561 | The ETF sold 224 shares of COO on 2025-06-20. The shares were previously bought for an average price of USD 87.0974. The The Cooper Companies, Inc. Common Stock shares were sold for -20.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,949 The average price that the ETF previously sold COO share for is USD 94.5221 which is higher than the selling price of USD 69.47 on 2025-06-20. |
| HOLX - Hologic Inc | SELL | -248 @ USD 64.48 | USD -15,991 | The ETF sold 248 shares of HOLX on 2025-06-20. The shares were previously bought for an average price of USD 66.6156. The Hologic Inc shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 530 The average price that the ETF previously sold HOLX share for is USD 71.5899 which is higher than the selling price of USD 64.48 on 2025-06-20. |
| WST - West Pharmaceutical Services Inc | SELL | -78 @ USD 215.82 | USD -16,834 | The ETF sold 78 shares of WST on 2025-06-20. The shares were previously bought for an average price of USD 251.845. The West Pharmaceutical Services Inc shares were sold for -14.3% lower than average price of previous purchases. This resulted in an overall loss of USD 2,810 The average price that the ETF previously sold WST share for is USD 298.583 which is higher than the selling price of USD 215.82 on 2025-06-20. |
| MOH - MOH | SELL | -60 @ USD 294.01 | USD -17,641 | The ETF sold 60 shares of MOH on 2025-06-20. The shares were previously bought for an average price of USD 307.39. The MOH shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 803 The average price that the ETF previously sold MOH share for is USD 306.379 which is higher than the selling price of USD 294.01 on 2025-06-20. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -60 @ USD 294.01 | USD -17,641 | The ETF sold 60 shares of MOH on 2025-06-20. The shares were previously bought for an average price of USD 307.39. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 803 The average price that the ETF previously sold MOH share for is USD 306.379 which is higher than the selling price of USD 294.01 on 2025-06-20. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -218 @ USD 91.22 | USD -19,886 | The ETF sold 218 shares of ZBH on 2025-06-20. The shares were previously bought for an average price of USD 105.123. The Zimmer Biomet Holdings Inc shares were sold for -13.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,031 The average price that the ETF previously sold ZBH share for is USD 106.457 which is higher than the selling price of USD 91.22 on 2025-06-20. |
| DGX - Quest Diagnostics Incorporated | SELL | -124 @ USD 179.43 | USD -22,249 | The ETF sold 124 shares of DGX on 2025-06-20. The shares were previously bought for an average price of USD 168.271. The Quest Diagnostics Incorporated shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 1,384 The average price that the ETF previously sold DGX share for is USD 160.796 so the ETF has sold 124 shares on 2025-06-20 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -22 @ USD 1153.93 | USD -25,386 | The ETF sold 22 shares of MTD on 2025-06-20. The shares were previously bought for an average price of USD 1229.04. The Mettler-Toledo International Inc shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,652 The average price that the ETF previously sold MTD share for is USD 1234.66 which is higher than the selling price of USD 1153.93 on 2025-06-20. |
| MTD - AMUNDI EUR GOV 710 | SELL | -22 @ USD 1153.93 | USD -25,386 | The ETF sold 22 shares of MTD on 2025-06-20. The shares were previously bought for an average price of USD 1229.04. The AMUNDI EUR GOV 710 shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,652 The average price that the ETF previously sold MTD share for is USD 1234.66 which is higher than the selling price of USD 1153.93 on 2025-06-20. |
| STE - STERIS plc | SELL | -110 @ USD 235.67 | USD -25,924 | The ETF sold 110 shares of STE on 2025-06-20. The shares were previously bought for an average price of USD 223.709. The STERIS plc shares were sold for 5.3% higher than average price of previous purchases. This sale made a profit of USD 1,316 The average price that the ETF previously sold STE share for is USD 217.331 so the ETF has sold 110 shares on 2025-06-20 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -552 @ USD 54.4 | USD -30,029 | The ETF sold 552 shares of CNC on 2025-06-20. The shares were previously bought for an average price of USD 59.5126. The Concurrent Technologies Plc shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,822 The average price that the ETF previously sold CNC share for is USD 59.9016 which is higher than the selling price of USD 54.4 on 2025-06-20. |
| DXCM - DexCom Inc | SELL | -434 @ USD 80 | USD -34,720 | The ETF sold 434 shares of DXCM on 2025-06-20. The shares were previously bought for an average price of USD 78.2993. The DexCom Inc shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of USD 738 The average price that the ETF previously sold DXCM share for is USD 76.1592 so the ETF has sold 434 shares on 2025-06-20 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -88 @ USD 523.92 | USD -46,105 | The ETF sold 88 shares of IDXX on 2025-06-20. The shares were previously bought for an average price of USD 450.097. The IDEXX Laboratories Inc shares were sold for 16.4% higher than average price of previous purchases. This sale made a profit of USD 6,496 The average price that the ETF previously sold IDXX share for is USD 433.68 so the ETF has sold 88 shares on 2025-06-20 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -652 @ USD 73.83 | USD -48,137 | The ETF sold 652 shares of EW on 2025-06-20. The shares were previously bought for an average price of USD 71.4954. The Edwards Lifesciences Corp shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 1,522 The average price that the ETF previously sold EW share for is USD 70.698 so the ETF has sold 652 shares on 2025-06-20 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -318 @ USD 168.42 | USD -53,558 | The ETF sold 318 shares of BDX on 2025-06-20. The shares were previously bought for an average price of USD 219.954. The Becton Dickinson and Company shares were sold for -23.4% lower than average price of previous purchases. This resulted in an overall loss of USD 16,388 The average price that the ETF previously sold BDX share for is USD 220.093 which is higher than the selling price of USD 168.42 on 2025-06-20. |
| ZTS - Zoetis Inc | SELL | -494 @ USD 157.17 | USD -77,642 | The ETF sold 494 shares of ZTS on 2025-06-20. The shares were previously bought for an average price of USD 166.531. The Zoetis Inc shares were sold for -5.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,624 The average price that the ETF previously sold ZTS share for is USD 171.026 which is higher than the selling price of USD 157.17 on 2025-06-20. |
| RVTY - Revvity Inc. | SELL | -2,064 @ USD 94.99 | USD -196,059 | The ETF sold 2064 shares of RVTY on 2025-06-20. The shares were previously bought for an average price of USD 110.222. The Revvity Inc. shares were sold for -13.8% lower than average price of previous purchases. This resulted in an overall loss of USD 31,439 The average price that the ETF previously sold RVTY share for is USD 112.552 which is higher than the selling price of USD 94.99 on 2025-06-20. |
| CRL - Creightons Plc | SELL | -1,403 @ USD 147.45 | USD -206,872 | The ETF sold 1403 shares of CRL on 2025-06-20. The shares were previously bought for an average price of USD 166.213. The Creightons Plc shares were sold for -11.3% lower than average price of previous purchases. This resulted in an overall loss of USD 26,324 The average price that the ETF previously sold CRL share for is USD 185.776 which is higher than the selling price of USD 147.45 on 2025-06-20. |
| IQV - IQVIA Holdings Inc | SELL | -1,340 @ USD 154.73 | USD -207,338 | The ETF sold 1340 shares of IQV on 2025-06-20. The shares were previously bought for an average price of USD 186.975. The IQVIA Holdings Inc shares were sold for -17.2% lower than average price of previous purchases. This resulted in an overall loss of USD 43,208 The average price that the ETF previously sold IQV share for is USD 194.379 which is higher than the selling price of USD 154.73 on 2025-06-20. |
| MRK - Marks Electrical Group PLC | SELL | -2,798 @ USD 79.06 | USD -221,210 | The ETF sold 2798 shares of MRK on 2025-06-20. The shares were previously bought for an average price of USD 90.3054. The Marks Electrical Group PLC shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 31,465 The average price that the ETF previously sold MRK share for is USD 97.2201 which is higher than the selling price of USD 79.06 on 2025-06-20. |
| MRK - Merck & Company Inc | SELL | -2,798 @ USD 79.06 | USD -221,210 | The ETF sold 2798 shares of MRK on 2025-06-20. The shares were previously bought for an average price of USD 90.3054. The Merck & Company Inc shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 31,465 The average price that the ETF previously sold MRK share for is USD 97.2201 which is higher than the selling price of USD 79.06 on 2025-06-20. |
| ALGN - Align Technology Inc | SELL | -1,255 @ USD 181.79 | USD -228,146 | The ETF sold 1255 shares of ALGN on 2025-06-20. The shares were previously bought for an average price of USD 187.013. The Align Technology Inc shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 6,555 The average price that the ETF previously sold ALGN share for is USD 212.826 which is higher than the selling price of USD 181.79 on 2025-06-20. |
| CAH - Cardinal Health Inc | SELL | -1,402 @ USD 163.4 | USD -229,087 | The ETF sold 1402 shares of CAH on 2025-06-20. The shares were previously bought for an average price of USD 132.231. The Cardinal Health Inc shares were sold for 23.6% higher than average price of previous purchases. This sale made a profit of USD 43,699 The average price that the ETF previously sold CAH share for is USD 124.73 so the ETF has sold 1402 shares on 2025-06-20 at a higher price than the previous selling average. |
| DVA - DaVita HealthCare Partners Inc | SELL | -1,772 @ USD 136.94 | USD -242,658 | The ETF sold 1772 shares of DVA on 2025-06-20. The shares were previously bought for an average price of USD 152.269. The DaVita HealthCare Partners Inc shares were sold for -10.1% lower than average price of previous purchases. This resulted in an overall loss of USD 27,163 The average price that the ETF previously sold DVA share for is USD 152.541 which is higher than the selling price of USD 136.94 on 2025-06-20. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -491 @ USD 509.72 | USD -250,273 | The ETF sold 491 shares of REGN on 2025-06-20. The shares were previously bought for an average price of USD 682.472. The Regeneron Pharmaceuticals Inc shares were sold for -25.3% lower than average price of previous purchases. This resulted in an overall loss of USD 84,821 The average price that the ETF previously sold REGN share for is USD 735.144 which is higher than the selling price of USD 509.72 on 2025-06-20. |
| TMO - Time Out Group plc | SELL | -1,310 @ USD 397.88 | USD -521,223 | The ETF sold 1310 shares of TMO on 2025-06-20. The shares were previously bought for an average price of USD 506.615. The Time Out Group plc shares were sold for -21.5% lower than average price of previous purchases. This resulted in an overall loss of USD 142,443 The average price that the ETF previously sold TMO share for is USD 513.688 which is higher than the selling price of USD 397.88 on 2025-06-20. |
| ELV - Elevance Health Inc | SELL | -1,761 @ USD 374.52 | USD -659,530 | The ETF sold 1761 shares of ELV on 2025-06-20. The shares were previously bought for an average price of USD 406.476. The Elevance Health Inc shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of USD 56,275 The average price that the ETF previously sold ELV share for is USD 401.036 which is higher than the selling price of USD 374.52 on 2025-06-20. |
| ELV - Elevance Health Inc | SELL | -1,761 @ USD 374.52 | USD -659,530 | The ETF sold 1761 shares of ELV on 2025-06-20. The shares were previously bought for an average price of USD 406.476. The Elevance Health Inc shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of USD 56,275 The average price that the ETF previously sold ELV share for is USD 401.036 which is higher than the selling price of USD 374.52 on 2025-06-20. |
| CI - Cigna Corp | SELL | -2,389 @ USD 314.35 | USD -750,982 | The ETF sold 2389 shares of CI on 2025-06-20. The shares were previously bought for an average price of USD 316.233. The Cigna Corp shares were sold for -0.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,498 The average price that the ETF previously sold CI share for is USD 312.91 so the ETF has sold 2389 shares on 2025-06-20 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -2,150 @ USD 377.5 | USD -811,625 | The ETF sold 2150 shares of HCA on 2025-06-20. The shares were previously bought for an average price of USD 342.239. The HCA Holdings Inc shares were sold for 10.3% higher than average price of previous purchases. This sale made a profit of USD 75,811 The average price that the ETF previously sold HCA share for is USD 330.041 so the ETF has sold 2150 shares on 2025-06-20 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -3,671 @ USD 302.01 | USD -1,108,679 | The ETF sold 3671 shares of UNH on 2025-06-20. The shares were previously bought for an average price of USD 499.401. The UnitedHealth Group Incorporated shares were sold for -39.5% lower than average price of previous purchases. This resulted in an overall loss of USD 724,622 The average price that the ETF previously sold UNH share for is USD 538.891 which is higher than the selling price of USD 302.01 on 2025-06-20. |